Osteogenic differences in cultured rat periosteal cells under hypoxic and normal conditions

Experimental and Therapeutic Medicine

Volumn 3, Issue 2, 2012, Pages 165-170

  Ichijima, Takehiro ^a   Matsuzaka, Kenichi ^a   Tonogi, Morio ^a   Yamane, Gen Yuki ^a   Inoue, Takashi ^a  

^a TOKYO DENTAL COLLEGE   (Japan)

Author keywords

Hypoxia; Hypoxia inducible factor 1 ; Osteogenic; Periosteum; Periostin

Indexed keywords

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; BONE SIALOPROTEIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; OSTEOCALCIN; TRANSCRIPTION FACTOR RUNX2; VASCULOTROPIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE CELL; BONE DEVELOPMENT; CALVARIA; CELL CULTURE; CELL HYPOXIA; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; IN VITRO STUDY; MALE; NONHUMAN; PERIOSTEUM; PROTEIN EXPRESSION; RAT; TISSUE CULTURE;

EID: 84855385025     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2011.393     Document Type: Article

References (50)

1. Zheng Y, Ringe J, Liang Z, et al: Osteogenic potential of human periosteum-derived progenitor cells in PLGA scaffold using allogeneic serum. J Zhejiang Univ 7: 817-824, 2006.
2. Hayashi O, Katsube Y, Hirose M, et al: Comparison of osteogenic ability of rat mesenchymal stem cells from bone marrow, periosteum, and adipose tissue. Calcif Tissue Int 82: 238-247, 2008.
3. Gallie WE and Robertson DE: The periosteum. Can Med Assoc J 4: 33-36, 1914.
4. Okuda K, Tanabe H, Suzuki K, et al: Platelet-rich plasma combined with a porous hydroxyapatite graft for the treatment of intrabony periodontal defects in humans:a comparative controlled clinical study. J Periodontal Res 76: 890-898, 2005.
5. Yamamiya K, Okuda K, Kawase T, et al: Tissue-engineered cultured periosteum sheets combined with platelet-rich plasma and porous hydroxyapatite graft in treating human osseous defects. J Periodontol 79: 811-818, 2008.
6. Kawase T, Okuda K, Kogami H, et al: Human periosteum-derived cells combined with superporous hydroxyapatite blocks used as an osteogenic bone substitute for periodontal regenerative therapy: an animal implantation study using nude mice. J Periodontol 81: 420-427, 2010.
7. Mase J, Mizuno H, Okada K, et al: Cryopreservation of cultured periosteum: Effect of different cryoprotectants and pre-incubation protocols on cell viability and osteogenic potential. Cryobiology 52: 182-192, 2006.
8. Okuda K, Yamamiya K, T Kawase, et al: Treatment of human infrabony periodontal defects by grafting human cultured periosteum sheets combined with platelet-rich plasma and porous hydroxyapatite granules: Case series. J Int Acad Periodontol 11: 206-213, 2009.
9. Thomas ED: In vitro studies of erythropoiesis. II. The effect of anoxia on heme synthesis. Blood 10: 612-615, 1955.
10. Miescher F: Uber die beziehungen zwischen meereschohe und beschaffenheit des blutes. Cor-Bl f Schweiz Aerzte 23: 809, 1893.
11. Wan C, Shao J, Shawn RG, et al: Role of HIF-1a in skeletal development. Ann New York Acid Sci 1192: 322-326, 2010.
12. Amemiya K, Kaneko Y, Inoue T, et al: Pulp cell responses during hypoxia and reoxygenation in vitro. Eur J Oral Sci 111: 32-38, 2003.
13. Amemiya H, Matsuzaka K, Inoue T, et al: Cellular responses of rat periodontal ligament cells under hypoxia and re-oxygenation conditions in vitro. J Periodontal Res 43: 322-327, 2008.
14. Somiya H, Matsuzaka K, Inoue T, et al: Molecular and morphological analyse of the osteogenic activity of rat cultured periosteum cells in vivo and in vitro. Oral Med Pathol 14: 19-28, 2009.
15. Senzui S, Matsuzaka K, Inoue T, et al: Responses of immature dental pulp cells to hypoxic stimulation. Oral Med Pathol 14: 107-111, 2010.
16. Nowak TS: Synthesis of a stress protein following transient ischemia in the gerbil. J Neurochem 45: 1635-1641, 1985.
17. Pittenger MF, Alastair M and Marshak R: Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147, 1999.
18. Ringe J, Leinhase I, Stich S, et al: Human mastoid periosteum-derived stem cells: promising candidates for skeletal tissue engineering. J Tissue Eng Regen Med 2: 136-146, 2008.
19. Pierre C: Bone marrow mesenchymal stem cells: historical overview and concepts. Hum Gene Ther 21: 1045-1056, 2010.
20. Sakaguchi Y, Sekiya I, Muneta T, et al: Comparison of human stem cells derived from various mesenchymal tissues. Arthritis Rheum 52: 2521-2529, 2005.
21. Krzysztof H and Wlodarski M: Normal and heterotopic periosteum. Clin Orthop Relat Res 241: 265-277, 1989.
22. Jeroen E and Frank PL: Species specificity of ectopic bone formation using periosteum-derived mesenchymal progenitor cells. Tissue Eng 12: 2203-2213, 2006.
23. Wei F, Crawford R and Xiao Y: Structural and cellular differences between metaphyseal and disphyseal periosteum in different aged rats. Bone 42: 81-89, 2008.
24. Wei F, Stefan R, Xiao Y, et al: Structural and cellular features in metaphyseal and disphyseal periosteum of osteoporotic rats. J Mol Histol 10: 81-89, 2010.
25. Beau J, Robert S, Peter C, et al: Hypoxia-amplified proliferation of human dental pulp cells. J Dent Res 25: 818-823, 2009.
26. Ueno Y, Kitamura C, Nishihara T, et al: Re-oxygenation improves hypoxia-induced pulp cell arrest. J Dent Res 85: 824-828, 2006.
27. Kaneko S, Takamatsu K, Shinozaki N, et al: Individual tissue culture system in a disposable capsule with hypoxic atmosphere. Ann Cancer Res Therap 16: 8-11, 2008.
28. Jan D, Dennis L and Oosterwyck HV: Towards a quantitative understanding of oxygen tension and cell density evolution in fibrin hydrogels. Biomaterials 93: 1-12, 2010.
29. Jiawei H, Damian C, Kent JL, et al: Oxygen tension differentially influences osteogenic differentiation of human adipose stem cells in 2D and 3D cultures. J Cell Biochem 110: 87-96, 2010.
30. Hirao M, Hashimoto J and Yoshikawa H: Oxygen tension is an important mediator of the transformation of osteoblasts to osteocytes. J Bone Miner Metab 25: 266-276, 2007.
31. Yoshida Y, Takahashi K, Yamanaka S, et al: Hypoxia enhances the generation of induced pluripotent stem cells. Cell Stem Cell 8: 237-241, 2009.
32. Hanada K, Solchaga LA and Brian J: BMP-2 induction and TGF-p1 modulation of rat periosteum cell chondrogenesis. J Cell Biochem 81: 284-294, 2001.
33. Pieter J, Frank E, Voncken RK, et al: A novel in vivo model to study endochondral bone formation; HIF-1a activation and BMP expression. Bone 40: 409-418, 2007.
34. Imai M, Ishibashi H, Shirasuna K, et al: Inhibition of vascular endothelial growth factor in oral cancer cells by HIF-1 decoy. J Jpn Stomatol 54: 22-28, 2005.
35. Chao W, Gillbert SR, Clemens L, et al: Activation of the hypoxia-inducible factor-1a pathway accelerates bone regeneration. Proc Natl Acad Sci USA 15: 686-691, 2008.
36. Akiyama M and Nakamura M: Bone regeneration and neovascu-larization processes in a pellet culture system for periosteal cells. Cell Transplant 18: 443-452, 2009.
37. Ryan C, Riddle RK, Thomas L, et al: Role of hypoxia-inducible factor-1a in angiogenic-osteogenic coupling. J Mol Med 87: 583-590, 2009.
38. Nagano M, Kimura K, Ohneda O, et al: Hypoxia responsive mesenchymal stem cells derived from human umbilical cord blood are effective for bone repair. Stem Cells Dev 19: 1195-1209, 2010.
39. Hwang J, Weng J, Kuo W, et al: Hypoxia-induced compensatory effects as related to shh and HIF1a in ischemia embryo rat heart. Mol Cell Biochem 311: 1215-1220, 2008.
40. Komori T, Yagi H, Nomura S, et al: Target disruption of Cbfa1 result in a complete lack of bone formation owing to maturation arrest of osteoblasts. Cell 89: 755-764, 1997.
41. Otto F, Thornell AP, Crompton T, et al: Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89: 765-771, 1997.
42. Kobayashi H, Gao Y and Komori K: Multilineage differentiation of Cbfal deficient calvial cells in vitro. Biochem Biophys Res Commun 273: 630-636, 2000.
43. Liu W, Toyosawa S, Furuichi T, et al: Overexpression of Cbfa1 in osteoblasts inhibits osteoblast maturation and causes osteopenia with multiple fractures. J Cell Biol 153: 87-100, 2001.
44. Wang Q, Huang C, Zhang X, et al: Expression of endogenous BMP-2 in periosteal progenitor cells is essential for bone healing. Bone 10: 1-9, 2010.
45. Horiuchi K, Amizuka N, Kudo A, et al: Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor p. J Bone Miner Res 14: 1239-1249, 1999.
46. Gillan L, Matei D, Chang B, et al: Periostin secreted by epithelial ovarian carcinoma is a ligand for alpha-V/beta3 and alpha-V/beta5 integrins and promotes cell motility. Canc Res 62: 5358-5364, 2002.
47. Kudo Y, Ogawa I, Takata T, et al: Periostin promotes invasion and anchorage-independent growth in the metastatic prosess of head and neck cancer. Canc Res 14: 6928-6935, 2006.
48. Shao R, Bao S, Dang T, et al: Acquired expression of periostin by human breast cancers promotes tumor angiogenesis through up-regulation of vascular endothelial growth factor receptor 2 expression. Mol Cell Biol 24: 3992-4003, 2004.
49. Shimazaki M, Nakamura K, Kudo A, et al: Periostin is essential for cardiac healing after acute myocardial infarction. J Exp Med 205: 295-303, 2008.
50. Tseng W, Yang S, Tang C, et al: Hypoxia induces BMP-2 expression via ILK, Akt, mTOR, and HIF-1 pathways in osteo-blasts. J Cell Physiol 223: 810-818, 2010.